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Abstract
It is now well established that simian immunodeﬁciency viruses (SIVs) from chimpanzees (SIVcpz) and gorillas (SIVgor) from west Central
Africa are at the origin of HIV-1/AIDS. Apes are also infected with other retroviruses, notably simian T-cell lymphotropic viruses (STLVs) and
simian foamy viruses (SFVs), that can be transmitted to humans. We discuss the actual knowledge on SIV, STLV and SFV infections in chim-
panzees, gorillas, and bonobos. We especially elaborate on how the recent development of non-invasive methods has allowed us to identify
the reservoirs of the HIV-1 ancestors in chimpanzees and gorillas, and increased our knowledge of the natural history of SIV infections in
chimpanzees. Multiple cross-species events with retroviruses from apes to humans have occurred, but only one transmission of SIVcpz from
chimpanzees in south-eastern Cameroon spread worldwide, and is responsible for the actual HIV pandemic. Frequent SFV transmissions have
been recently reported, but no human-to-human transmission has been documented yet. Because humans are still in contact with apes, identi-
ﬁcation of pathogens in wild ape populations can signal which pathogens may be cause risk for humans, and allow the development of serolog-
ical and molecular assays with which to detect transmissions to humans. Finally, non-invasive sampling also allows the study of the impact of
retroviruses and other pathogens on the health and survival of endangered species such as chimpanzees, gorillas, and bonobos.
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HIV/AIDS is the most devastating infectious disease to have
emerged in the 20th century. Like the majority of emerging
infectious disease events, HIV has a zoonotic origin in wildlife
[1]. It is now well established that simian immunodeﬁciency
viruses (SIVs) from chimpanzees and gorillas from west Cen-
tral Africa are at the origin of HIV-1/AIDS [2]. Apes are also
infected with other retroviruses, notably simian T-cell lym-
photropic viruses (STLVs) and simian foamy viruses (SFV).
Here, we review the current knowledge on retroviral infec-
tions in African apes.
SIVs
SIV infection in chimpanzees
According to mitochondrial DNA sequences, chimpanzees
can be divided into four distinct subspecies ([3]) that are also
geographically separated across western and equatorial
Africa (Fig. 1). The ﬁrst SIV strains from chimpanzees (SIV-
cpz) were isolated from two captive wild-born Pan troglodytes
troglodytes chimpanzees in Gabon almost 25 years ago [4].
Sequence and phylogenetic analysis showed that SIVcpz was
closely related to HIV-1, and cross-species transmission of
SIVs from chimpanzees was suspected to be at the origin of
the HIV-1 epidemic [5]. In order to better deﬁne the origin
of HIV-1, studies to further document SIV prevalence and
genetic diversity were initially performed on blood samples
drawn from captive animals. These studies revealed low pre-
valences, and resulted in the isolation of only a handful of
SIVcpz strains. However, phylogenetic analysis of the few
available SIVcpz strains suggested two distinct SIVcpz lin-
eages, according to the host subspecies: SIVcpzPtt from cen-
tral chimpanzees (P. t. troglodytes) and SIVcpzPts from eastern
chimpanzees (P. t. schweinfurthii) [6–9]. The majority of these
chimpanzees were captured as infants, so the results for
prevalence and genetic diversity do not reﬂect the situation
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in wild populations. The major issues in studying SIVcpz
infection in wild chimpanzees are their endangered status
and the fact that they live in isolated forest regions. The
development of non-invasive methods for the detection and
characterization of SIVcpz in faecal and urine samples
boosted the search for new SIVcpz strains in wild ape popu-
lations in the vast tropical forest of Central Africa [10,11].
Moreover, faecal samples can also be used to conﬁrm the
species and subspecies of the host, and individuals and their
sex can be identiﬁed by analysis of DNA short tandem
repeats (Fig. 2).
To date, more than 7000 faecal samples from nearly 90
ﬁeld sites across the entire chimpanzee home range have
been analysed. These studies revealed SIVcpz infection at
multiple sites across Central Africa, but SIVcpz seropreva-
lence rates varied widely, from 30–50% in some chimpanzee
communities from west Central and East Africa, to rare
cases or absence of infection in others [2,12,13] (Li et al.,
17th Conference on Retroviruses and Opportunistic Infec-
tions, 2010, Abstract 440). These studies also conﬁrmed sub-
species-speciﬁc clustering, and showed that SIVcpzPtt strains
from P. t. troglodytes are signiﬁcantly more closely related to
HIV-1 strains from humans. Moreover, the ancestors of HIV-
1 M and HIV-1 N could be traced to distinct chimpanzee
communities in south-eastern and south-central Cameroon
(Fig. 1) [2]. Despite testing of numerous samples of wild and
captive P. t. verus, largely exported from West Africa to pri-
mate centres in Europe and the USA, no SIV infection has
been detected in this subspecies [14,15]. Also, all P. t. ellioti
samples were SIV-negative [2,12].
These data suggest that chimpanzees acquired SIVcpz after
the evolutionary divergence and geographical separation of
the West African and Nigerian subspecies from the Central
and East African subspecies [16]. Detailed analysis of the SIV-
cpz genome revealed that SIVcpz is a recombinant virus,
resulting from cross-species transmission events followed by
recombination between SIVrcm from red-capped mangabeys
and a strain from the SIVgsn/mus/mon lineage infecting
greater-spot-nosed, mustached and mona monkeys [17].





































FIG. 1. HIV-1 is derived from simian immunodeﬁciency viruses (SIVs) circulating in chimpanzees and/or gorillas from west Central Africa. Evolu-
tionary relationships of SIVcpzPts infecting eastern chimpanzees (Pan troglodytes schweinfurthii) are in blue, those of SIVcpzPtt infecting central
chimpanzees (Pan troglodytes troglodytes) are in red, those of SIVgor infecting western lowland gorillas (Gorilla gorilla gorilla) are in green, and those
of HIV-1 group M, N, O and P strains in humans are in black, based on maximum likelihood phylogenetic analysis of partial Env (gp41)
sequences. Horizontal branch lengths are drawn to scale (the scale bar indicates 0.1 substitutions per site), and bootstrap values >80% are rep-
resented by grey asterisks. The geographical range of the four chimpanzee subspecies are shown in the upper right panel. The geographical
ranges of gorilla species and bonobos are shown in the lower right panel. The arrows between the phylogenetic tree and the map indicate the
ape reservoirs with the ancestors of or most closely related strains to the different HIV-1 groups. DRC, Democratic Republic of Congo.
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while hunting and consuming monkeys [18]. The current
range of the central chimpanzee overlaps with the ranges of
red-capped mangabeys and the various Cercopithecus species
infected with SIVgsn/mus/mon. The recombination therefore
most likely occurred in a chimpanzee from west Central
Africa, and this new virus became the common ancestor of
today’s SIVcpz lineages. Despite the fact that chimpanzees
can be frequently exposed to infected monkeys, no other
SIV has been observed among them [19,20].
Pathogenicity of SIVcpz in chimpanzees
Initially, like other SIVs in their natural hosts, SIVcpz was also
thought to be non-pathogenic for chimpanzees. This has
been challenged recently by a study initiated in 2001 on two
habituated populations of chimpanzees (P. t. schweinfurthii) at
Gombe National Park in Tanzania [21]. The SIV status was
assessed by analysing faecal samples at regular time intervals
for more than 10 years. SIV infection was associated with a
10-fold to a 16-fold increase in age-corrected risk of death.
Fertility was signiﬁcantly reduced in SIV-positive females, in
terms of both birth rate and survival of offspring. Immunohis-
tochemistry and in situ hybridization of post-mortem spleen
and lymph node samples showed lower CD4+ T-cell counts
in SIV-positive than in SIV-negative individuals. CD4+ T-cell
counts and tissue samples strongly resembled the histopa-
thology of human end-stage AIDS patients. SIVcpz could thus
be causing the decline of chimpanzee communities, and could
also explain the uneven distribution of SIVcpz throughout
Central Africa [22]. No data are currently available on wild
P. t. troglodytes chimpanzees. However, we recently described
a progressive SIV infection similar to HIV infection in humans
in a naturally SIV-infected P. t. troglodytes chimpanzee. This
animal had low CD4 counts, severe thrombocytopenia,
weight loss, and unusually frequent periods of infection with
diverse pathogens [23]. Overall, SIVcpz most likely has a neg-
ative impact on the health, reproduction and survival of both
chimpanzee subspecies in Central Africa.
SIV infection in gorillas
Gorillas are classiﬁed into two species, the western Gorilla
gorilla and eastern Gorilla beringei, which in turn are subdi-
vided into four subspecies (G. g. gorilla, G. g. diehli, G. b. berin-
gei, and G. b. graueri) [24]. As shown in Fig. 1, the range of
gorillas overlaps with that of chimpanzees, especially in west
Central Africa. Analysis of about 200 faecal samples from
southern Cameroon showed that gorillas are also infected
with an SIV, termed SIVgor [25]. Surprisingly, this lineage fell
within the radiation of SIVcpz, and was closely related to
HIV-1 groups P and O (Fig. 1). The phylogenetic relation-
ships between SIVcpz, SIVgor and HIV-1 show that chimpan-
zees were the original reservoir of SIVs found in gorillas and
humans, and that P. t. troglodytes apes were most likely the
original source of SIVgor [25–27]. In addition, an ancestral
SIVcpzPtt lineage from which SIVgor and HIV-1 group O
viruses are derived has been identiﬁed in the form of mosaic
pol fragments in present-day SIVcpzPtt recombinants [26].
The methods of transmission and the exact origin of SIV-
gor infection in gorillas are not yet resolved. Because of the
extensive overlap in habitat and diet [28–31], direct encoun-
ters between gorillas and chimpanzees seem inevitable, but
they have rarely been observed, and have been described as
primarily non-aggressive [32]. However, it cannot be
excluded that physical encounters between chimpanzees and
gorillas, possibly involving biting or other forms of aggres-
sion, occurred in the past. Moreover, sharing the same habi-
tat could also lead to indirect contact with the virus of the
other species (e.g. disease outbreaks such as anthrax, Ebola,
etc.) [33].
FIG. 2. Non-invasive methods for the
detection of retroviral infections in fae-
ces. Collection of faecal samples at nest-
ing sites of gorillas (left upper panel)
and chimpanzees (right upper panel) and
subsequent storage in RNA later (mid-
dle). Photographs by Sabrina Locatelli
and Florian Liegeois. mtDNA, mitochon-
drial DNA.
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Subsequent screening of faecal gorilla samples from 30
ﬁeld sites, mainly from western lowland gorillas (G. g. gorilla)
in southern Cameroon and the Central African Republic, but
also from eastern gorillas (G. b. graueri), revealed an overall
seroprevalence of SIVgor of 1.6%. SIVgor appears to be
much less common in gorillas than SIVcpz is in chimpanzees;
SIVgor was only documented in western gorillas, and at only
four ﬁeld sites [34]. At two of these sites, however, the SIV-
gor seroprevalence was close to 5%, indicating efﬁcient virus
spread within and between different communities. It remains
possible that SIVgor is even more prevalent in other parts of
the home range of western lowland gorillas. Similarly, as
observed for SIVcpz, SIVgor strains cluster according to their
collection site of origin.
As gorillas may have acquired SIV only recently from
chimpanzees, it is possible that SIVgor is also pathogenic for
its host. Actually, there are no captive gorillas naturally
infected with SIVgor and no habituated gorilla groups
infected with SIVgor. The impact of such infection on the
survival of gorillas can only be determined by a non-invasive
approach in the wild.
SIVs from chimpanzee and gorillas, and the origin of HIV-1
It is now clear that central chimpanzees (P. t. troglodytes) are
the reservoirs for the pandemic HIV-1 group M strain and
also for HIV-1 N [2]. HIV-1 P is most likely of gorilla origin,
but the reservoirs of the direct ancestors of HIV-1 O have
not been identiﬁed yet; moreover the current data do not
allow differentiation between a chimpanzee or a gorilla res-
ervoir [25–27,34]. More studies are therefore still needed to
identify the direct ancestors of HIV-1 O and P in gorillas
and/or chimpanzees. The cross-species transmissions giving
rise to HIV-1 most likely occurred in western equatorial
Africa, within the geographical ranges of central chimpanzees
and western gorillas. This coincides with the geographical
area of HIV-1 N, O and P infections, which are also mainly
restricted to Cameroon [35]. Only, HIV-1 M has spread
across Africa and all of the other continents, but the reser-
voir of the ancestors of HIV-1 M does not coincide with the
epicentre of the HIV-1 epidemic [2,36]. The latter has been
identiﬁed around Kinshasa, the capital city of the Democratic
Republic of Congo (DRC), at a distance of almost 1000 km.
HIV-1 M (subtypes A and D) was already circulating in
humans in Kinshasa 20 years before the AIDS epidemic was
recognized in the USA; HIV-1 was identiﬁed in a serum sam-
ple from 1959 and a biopsy sample from 1960 [37,38].
Molecular clock analyses estimated the date of the most
recent common ancestor of HIV-1 M to be around 1908
(1884–1924), and the date for the origin of the HIV-1 O
radiation to be around 1920 (1890–1940) [39–41]. HIV-1 N
seems to be a more recent cross-species transmission, the
date of the most recent common ancestor being estimated
to be around 1963 (1948–1977) [39], and, ﬁnally, HIV-1 P
was only discovered in 2009 [27]. A combination of several
factors (viral, host, socio-economic, demographic, etc.) are
thus most likely to have been involved in the subsequent efﬁ-
cient spread of HIV-1 M [42,43].
STLV in Apes
Human T-lymphotropic viruses (HTLVs) and STLVs are col-
lectively called primate T-lymphotrophic viruses. In contrast
to HIV, the majority of HTLV infections remain asymptom-
atic, but approximately 5% of them are associated with
severe diseases such as adult T-cell leukaemia/lymphoma or
an inﬂammatory disease of the central nervous system called
HTLV-1-associated myelopathy/tropical spastic paraparesis
[44,45]. Simian counterparts, STLV-1 to STLV-3, have been
described for HTLV-1 to HTLV-3 in humans [46]. No simian
analogue of the recently discovered HTLV-4 has been identi-
ﬁed yet, and no human analogue has been reported to date
for the tentatively identiﬁed STLV-5 in a macaque species
from Asia [47]. STLV has been documented in more than 30
non-human primate (NHP) species from sub-Saharan Africa
and Asia, but few data are available on STLV infection in wild
apes [43]. Phylogenetic analysis shows that primate T-lym-
photrophic viruss cluster by geography, rather than by host
species, suggesting multiple cross-species transmission events
between NHPs, and also from NHPs to humans [47–49].
STLV-1 belonging to the African subtype B has been docu-
mented in captive but wild-caught chimpanzees (P. t. ellioti
and P. t. troglodytes) and gorillas from west Central Africa
[50]. Approximately 70% of wild chimpanzees in Ivory Coast
are infected with STLV-1, and, in addition to subtype B, a
variant closely related to STLVs observed in the western red
colobus was identiﬁed, suggesting cross-species transmission
by predation [51]. STLV-2 has only been documented in
bonobos, an ape species endemic to DRC [52]. The initial
strains were isolated in captive animals, and STLV-2 DNA
was also recently identiﬁed in a faecal sample from a wild
bonobo in DRC [53]. No data are currently available on
STLV pathogenicity in wild apes; however, STLV-1 has occa-
sionally been associated with lymphoma or chronic fatal dis-
ease in captive gorillas [54,55].
Because many other monkey species are also infected
with STLV strains closely related to those that circulate
among chimpanzees and gorillas, it is not easy to determine
which primate species is at the origin of today’s HTLV-1
B subtypes in humans.
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SFVs
SFVs have been identiﬁed with a high prevalence in a wide
variety of primates, including prosimians, and New and Old
World NHPs; each species has been shown to harbour a
unique (species-speciﬁc) SFV strain, and no disease is associ-
ated with SFV infection in their natural hosts [56]. SFVs have
co-evolved with their NHP hosts for more than 30 million
years [56]. SFVs have been described in captive apes, and a
recent serological and molecular survey on faecal samples
showed a high SFV infection rate (44–100%) in wild chimpan-
zees from West, Central and East Africa [57–59]. Remark-
ably, SFVcpz strains clustered according to their subspecies of
origin [59]. No large-scale studies have yet been performed
on wild gorillas, but species-speciﬁc SFV infection has been
identiﬁed in wild-caught captive gorillas in Cameroon [60].
There is no human foamy virus, but SFV infections have
been reported in persons occupationally exposed to NHPs
and in a few hunters in Central Africa, with no consequences
for human health [61]. Efﬁcient transmission and high levels
of cross-species transmission of SFVs to humans after ape
bites, followed by viral persistence, have been reported in
Gabon and Cameroon [62,63]. No SFV epidemic has been
documented yet, and the apparent lack of human-to-human
SFV transmission represents an informative marker of con-
tact between human and NHPs and of transmission of simian
retroviruses to the human population.
Conclusion
Although the conditions and circumstances determining SIV,
STLV and SFV transmission from NHPs to humans are not
completely elucidated, exposure to blood or other secre-
tions of infected animals, through hunting and butchering of
bushmeat, or through bites and scratches from pet NHPs,
represent the most plausible source for human infection
(Fig. 3). Direct evidence for such events has been reported
recently for SFV in primate hunters in independent studies
in Cameroon and Gabon. The recent development of non-
invasive methods for the detection of retroviral infections
has allowed us to deﬁne the origin of HIV-1, and has signif-
icantly increased our knowledge of the natural history of
SIV infections in chimpanzees. However, our knowledge of
retroviral infections in wild apes is still incomplete with
regard to geographical areas and certain species. Currently,
almost no data are available for bonobos, or eastern low-
land and mountain gorillas. Importantly, despite their highly
endangered status, apes continue to be hunted, and remain
a potential source of human infections. SIVs from apes have
crossed the species barrier to humans on at least four
occasions in west Central Africa. Given the recent discov-
ery of the HIV-1 group P lineage, it would not be surprising
if additional cases of SIVcpz or SIVgor cross-species trans-
mission had occurred.
Finally, non-invasive sampling also allows large-scale stud-
ies on wild apes to prevent or trace the origin of other
epidemics, e.g. the origin of human Plasmodium falciparum
in gorillas in west Central Africa [64]. Non-invasive studies
also allow studies on the impact of retroviruses and other
pathogens on the health and survival of endangered spe-
cies.
Transparency Declaration
The authors declare they have no conﬂicts of interest.
(a) (b)
(c) FIG. 3. Human exposure to retrovirus-
es. Pictures taken between 2001 and
2009 in Cameroon and Democratic
Republic of Congo, illustrating bushmeat
(smoked (a), butchering (b)) and pet
chimpanzee as bushmeat byproducts (c).
Photographs by Bernadette Abela (a, c),
and Steve Ahuka-Mundeke (b).
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